SS Innovations International (SSII) Net Income towards Common Stockholders (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.02% |
| Dec 31, 2025 | 537.61% |
| Sep 30, 2025 | -1,348.42% |
| Jun 30, 2025 | 95.48% |
| Mar 31, 2025 | 66.27% |
| Dec 31, 2024 | -175.27% |
| Sep 30, 2024 | -108.72% |
| Jun 30, 2024 | -4.77% |
| Mar 31, 2024 | 83.42% |
| Dec 31, 2023 | -1,281.05% |
| Sep 30, 2023 | 33.94% |
| Jun 30, 2023 | 38.16% |
| Mar 31, 2023 | -191.03% |
| Dec 31, 2022 | -111.40% |
| Sep 30, 2022 | 35.32% |
| Jun 30, 2022 | -835.11% |
| Mar 31, 2022 | 77.22% |
| Dec 31, 2021 | 15.60% |
| Sep 30, 2021 | -1.43% |
| Jun 30, 2021 | -37.41% |
| Mar 31, 2021 | -35.26% |
| Dec 31, 2020 | 40.93% |
| Sep 30, 2020 | -70.46% |
| Jun 30, 2020 | 28.24% |
| Mar 31, 2020 | 70.87% |
| Dec 31, 2019 | 24.57% |
| Sep 30, 2019 | -159.27% |
| Jun 30, 2019 | -36.29% |
| Mar 31, 2019 | -80.47% |
| Dec 31, 2018 | 26.28% |
| Sep 30, 2018 | -44.65% |
| Jun 30, 2018 | 13.80% |
| Mar 31, 2018 | 49.70% |
| Dec 31, 2017 | -163.22% |
| Sep 30, 2017 | 3.90% |
| Jun 30, 2017 | 4.55% |
| Mar 31, 2017 | -0.76% |
| Dec 31, 2016 | 21.07% |
| Sep 30, 2016 | -470.89% |